Abiopharma

VTGN Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Vistagen Therapeutics, Inc.

Integer Holdings Corporation Securities Fraud Class Action Result of Overstated Demand and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Organon & Co. - Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use ofNEXPLANON® (etonogestrel implant) 68 mg Radiopaque

New Form SCHEDULE 13D/A - STAAR SURGICAL CO Filed: 2026-01-16 AccNo: 0001213900-26-005310 Size: 86 KB

New Form SCHEDULE 13D/A - STAAR SURGICAL CO Filed: 2026-01-16 AccNo: 0000921895-26-000097 Size: 14 KB

New Form 3 - BiomX Inc. Filed: 2026-01-16 AccNo: 0001213900-26-005298 Size: 6 KB

ResMed Inc. Daily Stock Update

New Form SCHEDULE 13D/A - Werewolf Therapeutics, Inc. Filed: 2026-01-16 AccNo: 0001609492-26-000002 Size: 40 KB

New Form SCHEDULE 13D/A - Celcuity Inc. Filed: 2026-01-16 AccNo: 0001072613-26-000056 Size: 110 KB

New Form 4/A - NEUROCRINE BIOSCIENCES INC Filed: 2026-01-16 AccNo: 0001643653-26-000005 Size: 8 KB

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

New Form 424B3 - AETHLON MEDICAL INC Filed: 2026-01-16 AccNo: 0001683168-26-000376 Size: 294 KB

New Form S-8 POS - Semler Scientific, Inc. Filed: 2026-01-16 AccNo: 0000950103-26-000623 Size: 24 KB

New Form S-8 POS - Semler Scientific, Inc. Filed: 2026-01-16 AccNo: 0000950103-26-000624 Size: 24 KB